The Project Management of Project Management - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

The Project Management of Project Management
This article presents an overview of ISPE's guide on project management.

Pharmaceutical Technology
Volume 36, Issue 9, pp. s26-s29

Delivery value

The guide was launched at the ISPE Annual Meeting in Dallas, Texas in November 2011 as a part of the project-management track. The launch, less than 18 months from kick-off, was due to a team effort born out of a combined desire to share knowledge, provide good practices to improve project outcomes, and demonstrate the value of project management across the industry.

The launch success was only the start of the final stage of the guide project: benefits realization. Success can only be truly determined by sustainable use of the guide, continual feedback from users, and continuous improvement.

To support the guide's objectives, the core team remain in place to assist ISPE by continuing to foster awareness of and educate the pharmaceutical industry about the guide. The members of the ISPE Project Management Community of Practice (PM COP) continue to promote the guide and its adoption in the pharmaceutical industry.

Table I: Benefits realization plan of the ISPE Project Good Practice Guide.
To support achievement of the benefits, key metrics were developed against each of the goals described previously (see Table I). These indicate a strong release of benefits in the first six months since the guide's launch.


Ultimately, the success of the guide will be its continued use and development within the industry. The objective of the guide project was to develop a resource to improve project delivery success, and the guide is only one aspect of the support the ISPE PM COP wants to have available to those involved in projects.

Ongoing development of the key areas, those that are different or more challenging for pharmaceutical projects, will continue, and the ISPE PM COP remains dedicated to this development.


The author of the article wishes to acknowledge the work completed by the PM GPG Core Team, all chapter teams, and the ISPE Guidance Document Executive Committee (GDEC) on this project.

Trish Melton, BSc (Hons), PhD, MBA, CEng, CSci, FIChemE, is managing director at MIME Solutions Ltd. and author team leader of the ISPE Good Practice Guide: Project Management for the Pharmaceutical Industry,


1. ISPE, ISPE Good Practice Guide: Project Management for the Pharmaceutical Industry (Tampa, FL, 2011).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here